Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

Regulatory Peptides

Volumn 71, Issue 1, 1997, Pages 15-21

  Heinrichs, S C ^a   Lapsansky, J ^a   Lovenberg, T W ^a   De Souza, E B ^a   Chalmers, D T ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Adrenocorticotropic hormone; Body weight; Defensive withdrawal; Oligonucleotide; Plus maze; Swim stressor

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; LEARNING; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; AUTORADIOGRAPHY; BODY WEIGHT; BRAIN; CARRIER PROTEINS; CORTICOTROPIN-RELEASING HORMONE; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; OLIGONUCLEOTIDES, ANTISENSE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

ANIMALIA;

EID: 0030870660     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01005-7     Document Type: Article

References (21)

1. Ambühl P, Gyurko R, Phillips MI. A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin ATI receptor. Regul Peptides 1995;59:171-82.
2. Behan DP, Heinrichs SC, Troncoso JC, Liu X-J, Kawas CH, Ling N, De Souza EB. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995;378:284-7.
3. Britton KT, McLeod S, Koob GF, Hauger R. Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress. Pharm Biochem Behav 1992;41:399-403.
4. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific sub-cortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 1995;15(10):6340-50.
5. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. Corticotropin-releasing factor receptors: from molecular biology to drug design. TIPS 1996;17:166-72.
6. Chen C, Dagnino Jr. R, De Souza EB, Grigoriadis DE, Huang CQ, Kim K-I, Liu Z, Moran T, Webb TR, Whitten JP, Xie YF, McCarthy JR. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists. J Med Chem 1996;39:4358-60.
7. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: An autoradiographic study. J Neurosci 1985;5:3189-203.
8. Grigoriadis DE, Liu X-J, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB. 1251-Tyr0-Sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2a receptors. Mol Pharmacol 1996;50:679-86.
9. Heinrichs SC, Menzaghi F, Merlo Pich E, Baldwin HA, Rassnick S, Britton KT, Koob GF. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to Stressors of varying type and intensity. Neuropsychopharmacology 1994;11(3):179-86.
10. Heinrichs SC, Merlo Pich E, Miczek KA, Britton KT, Koob GF. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 1992;581:190-7.
11. Koob GF, Heinrichs SC, Menzaghi F, Merlo Pich E, Britton KT. Corticotropin releasing factor, stress and behavior. Sem Neurosci 1994;6:221-9.
12. Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M, Holsboer F, Montkowski A. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Peptides 1995;59:229-39.
13. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinol 1995; 136:4139-42.
14. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 1994;269(2):564-72.
15. Phillips MI, Gyurko R. In vivo applications of antisense oligonucleotides for peptide research. Regul Peptides 1995;59:131-41.
16. Rodríguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M. Corticotropin-releasing factor (CRF) antagonist [D-Phe 12, NLE21,38, CalphaMeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 1996;276(1):56-64.
17. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, III TFD, Winston EN, Chen YL, Heym J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci (USA) 1996;93:10477-82.
18. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, Koob GF. Appetite-suppressing effects of urocortin, a novel CRF-related neuropeptide. Science 1996;273:1561-4.
19. Takahashi LK, Kalin NH, Vandenburgt JA, Sherman JE. Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci 1989;103:648-54.
20. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287-92.
21. Yang X-M, Gorman AL, Dunn AJ. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 1990;255(3):1064-70.